Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective.

PharmacoEconomics·2026
Same author

Assessment of Carbon Emission Impact of Semaglutide in Patients With Type 2 Diabetes in the United Kingdom Using an Innovative Modeling Approach.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Budget Impact Analysis of Stepping Down Patients from Long-Term Inappropriate Proton Pump Inhibitor Use to Episodic Alginate Treatment: NHS England Perspective.

Journal of health economics and outcomes research·2025
Same author

Assessing economic investment required to scale up bariatric surgery capacity in England: a health economic modelling analysis.

BMJ open·2024
Same author

Autophagy: a necessary evil in cancer and inflammation.

3 Biotech·2024
Same author

Natural Compound Dioscin Targeting Multiple Cancer Pathways through its High Affinity Binding to B Cell Lymphoma-2.

Current computer-aided drug design·2024

Related Experiment Video

Updated: Jul 1, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Synergistic Geroprotectors Mapping through Systems Machine Learning and Graph Neural Networks.

Yuvraj Sharma1, Asmita Das1

  • 1Department of Biotechnology, Delhi Technological University, Delhi, India.

Omics : a Journal of Integrative Biology
|June 30, 2026
PubMed
Summary

This study identifies natural compounds that target key aging pathways simultaneously. These compounds show potential for synergistic effects, offering a new strategy to combat multiple age-related disorders comprehensively.

Keywords:
aginggeroprotectorsgerosciencegraph neural networksmachine learningnatural compounds

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Related Experiment Videos

Last Updated: Jul 1, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Area of Science:

  • Geroscience
  • Computational Biology
  • Pharmacology

Background:

  • Aging hallmarks are shared across multiple age-related disorders (ARDs).
  • Current geroprotective interventions often lack mechanistic breadth, targeting isolated pathways.
  • A systems-level strategy is needed to modulate interconnected aging biology regulators.

Purpose of the Study:

  • To design a systems-level strategy targeting four key aging regulators: Nrf2/Keap1, mTORC1, AMPK, and SIRT1.
  • To identify natural compounds capable of executing this integrated geroprotective strategy using machine learning.
  • To predict synergistic combinations of natural compounds for comprehensive geroprotection.

Main Methods:

  • Developed a machine learning model to classify geroprotectors targeting Nrf2/Keap1, mTORC1, AMPK, and SIRT1.
  • Performed drug-likeness screening and molecular docking to assess compound properties and target binding.
  • Utilized a graph neural network model to predict synergistic combinations of natural compounds for ARDs.

Main Results:

  • Identified a subset of natural compounds with favorable pharmacokinetics and strong binding affinities to all four geroprotective targets.
  • Predicted five high-confidence synergistic pairs of natural compounds, including Baicalein, Pectolinarigenin, Phloretin, and Demethoxycurcumin.
  • Demonstrated the potential for a coordinated geroprotective response across diverse ARDs.

Conclusions:

  • A systems-level approach targeting multiple aging hallmarks can yield sustained geroprotective effects.
  • Computational methods can effectively identify natural compounds and combinations for integrated geroprotection.
  • Predicted natural compound combinations offer a promising strategy for synergistic and comprehensive treatment of multiple ARDs.